ARMP R&D Expenses
Armata Pharmaceuticals, Inc. Common Stock · R&D Expenses
ARMP R&D Expenses
Latest reported$25.59Mperiod ending
ARMP TTM R&D Expenses ($0.00 → $25.59M)
TTM R&D Expenses
High-resolution chart · PNG
ARMP r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 25,591,000 | |
| 24,399,000 | |
| 23,717,000 | |
| 26,097,000 | |
| 29,758,000 | |
| 31,839,000 | |
| 34,426,000 | |
| 33,904,000 | |
| 32,397,000 | |
| 32,181,000 | |
| 33,769,000 | |
| 35,410,000 | |
| 35,832,000 | |
| 36,593,000 | |
| 35,017,000 | |
| 30,262,000 | |
| 27,488,000 | |
| 23,693,000 | |
| 20,015,000 | |
| 20,181,000 | |
| 18,621,000 | |
| 16,044,000 | |
| 14,444,000 | |
| 11,132,000 | |
| 10,085,000 | |
| 10,513,000 | |
| 9,257,000 | |
| 8,964,000 | |
| 6,306,000 | |
| 4,922,000 | |
| 4,892,000 | |
| 4,607,000 | |
| 3,417,000 | |
| 2,855,000 | |
| 2,881,000 | |
| 2,593,000 | |
| 5,077,000 | |
| 5,188,000 | |
| 5,678,000 | |
| 6,091,000 | |
| 5,164,000 | |
| 5,000,000 | |
| 3,992,000 | |
| 3,895,000 | |
| 4,971,000 | |
| 5,770,000 | |
| 5,804,000 | |
| 5,829,000 | |
| 5,148,000 | |
| 6,867,000 | |
| 6,502,000 | |
| 6,874,000 | |
| 7,642,000 | |
| 6,167,000 | |
| 9,415,000 | |
| 11,092,000 | |
| 13,357,000 | |
| 15,183,000 | |
| 16,163,000 | |
| 16,845,000 | |
| 17,959,000 | |
| 17,709,000 | |
| 16,839,000 | |
| 16,088,000 | |
| 14,501,000 | |
| 14,482,000 | |
| 14,682,000 | |
| 16,212,000 | |
| 17,337,000 | |
| 18,199,000 | |
| 17,955,000 | |
| 17,570,000 | |
| 17,590,000 | |
| 17,288,000 | |
| 17,714,000 | |
| 17,393,000 | |
| 16,892,000 | |
| 17,197,000 | |
| 19,083,000 | |
| 22,820,000 | |
| 26,818,000 | |
| 31,315,000 | |
| 34,664,000 | |
| 35,879,000 | |
| 34,192,000 | |
| 31,546,000 | |
| 28,481,000 | |
| 24,087,000 | |
| 21,987,000 | |
| 19,312,000 | |
| 16,761,000 | |
| 15,856,000 | |
| 14,818,000 | |
| 14,300,000 | |
| 14,900,000 | |
| 14,200,000 | |
| 13,300,000 | |
| 13,300,000 | |
| 12,200,000 | |
| 12,400,000 |